Literature DB >> 12036303

Activation of the esophagin promoter during esophageal epithelial cell differentiation.

Kara N Smolinski1, John M Abraham, Rhonda F Souza, Jing Yin, Suna Wang, Yan Xu, Tong Tong Zou, Dehe Kong, A Steven Fleisher, Stephen J Meltzer.   

Abstract

Esophagin is a member of the small proline-rich protein family of cell envelope precursor proteins, which are expressed during squamous cell differentiation. Esophagin is expressed at high levels in normal esophageal epithelium, but its expression is absent from esophageal squamous cell carcinomas and adenocarcinomas. Moreover, loss of esophagin expression is present in areas of dysplasia or normal mucosa adjacent to carcinomas, suggesting that absence of esophagin may constitute a harbinger of early esophageal malignant transformation. A greater understanding of transcriptional control of esophagin may provide valuable insights into esophageal malignancy. Therefore, this study was undertaken in order to isolate and carry out initial characterization of a functional promoter for esophagin. A genomic clone containing esophagin was isolated and sequenced, including 2.7 kb of the esophagin promoter region. Esophagin expression was studied in response to various treatments of primary cultured human esophageal epithelial cells and squamous cell carcinoma cell lines. Calcium was the strongest inducer of the endogenous esophagin promoter, with induction occurring at 12-72 hours. In primary cultured esophageal epithelial cells, a region spanning 116 bp upstream of the transcriptional start site to 45 bp downstream was sufficient to direct low, basal, in vitro esophagin expression. However, responsiveness of primary esophageal cells to calcium required inclusion of promoter elements 1688 bp upstream of the transcriptional start site. Site-directed mutagenesis studies suggested a putative role for C/EBP-beta, OCT-1, and OCT-3 transcription factor binding sites in the minimal promoter region. In conjunction with published human in vivo studies, these data support the hypothesis that esophagin is a biomarker of esophageal squamous cell differentiation and provide an in vitro model to evaluate regulatory factors involved in this differentiation process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036303     DOI: 10.1006/geno.2002.6775

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Regulation of the atheroma-enriched protein, SPRR3, in vascular smooth muscle cells through cyclic strain is dependent on integrin alpha1beta1/collagen interaction.

Authors:  Amy L Pyle; James B Atkinson; Ambra Pozzi; Jeff Reese; Beate Eckes; Jeffrey M Davidson; Dan L Crimmins; Pampee P Young
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

2.  Emerging molecular targets in esophageal cancers.

Authors:  Julie G Izzo; Rajyalakshmi Luthra; Jennifer Sims-Mourtada; K S Clifford Chao; Jeffrey H Lee; Tsung-The Wu; Arlene M Correa; Madan Luthra; Bharat Aggarwal; Mien-Chie Hung; Jaffer A Ajani
Journal:  Gastrointest Cancer Res       Date:  2007

Review 3.  Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaei-Tavirani; Hadi Hasanzadeh; Sara Rahmati Rad; Sona Dalilan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

4.  Protective Effect of Dietary Calcium Intake on Esophageal Cancer Risk: A Meta-Analysis of Observational Studies.

Authors:  Qianwen Li; Lingling Cui; Yalan Tian; Han Cui; Li Li; Weifeng Dou; Haixia Li; Ling Wang
Journal:  Nutrients       Date:  2017-05-18       Impact factor: 5.717

5.  Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).

Authors:  Prasanna M Chandramouleeswaran; Dawen Shen; Anna J Lee; Alain Benitez; Kara Dods; Fiona Gambanga; Benjamin J Wilkins; Jamie Merves; Yuliana Noah; Sarit Toltzis; Jennifer H Yearley; Jonathan M Spergel; Hiroshi Nakagawa; Rene deWaal Malefyt; Amanda B Muir; Mei-Lun Wang
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.